Postprandial Effect of Olive Leaf Biscuits and Tea Consumption on Blood Biomarkers in Healthy Individuals
NCT ID: NCT06983145
Last Updated: 2025-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
30 participants
INTERVENTIONAL
2024-11-20
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will last 15 days and features a cross-over design involving three groups:
Control Group: Consumes biscuits made with butter, flour, sugar, and caramel coloring, along with natural mineral water.
Intervention Group A: Receives the same biscuits with added dried olive leaf powder, accompanied by the same water.
Intervention Group B: Eats the standard biscuits with olive leaf tea instead of water. On each study day, participants will consume their meal over 15 minutes, followed by the liquid within 10 minutes. After a 7-day washout period, the groups will switch treatments for the second phase. The procedure will be repeated on the 15th day, ensuring that all participants experience each condition. Blood samples will be collected before and at 60, 120, and 240 minutes post-meal for analysis. Statistical processing will then be conducted to evaluate the effects on biomarkers and antioxidant status.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Acute Effect of Novel Olive Oil on Postprandial Oxidative Stress Biomarkers (BioliveCT)
NCT05771571
Nutritional Intervention With Table Olives in Healthy Volunteers
NCT03886597
Immunomodulatory and Preventive Effects of Olive Leaf Tea Against COVID-19
NCT05222347
Absorption and Metabolism of Olive Leaf Extract and Its Effect on Vascular Reactivity and Cytokine Concentrations
NCT01479699
Olive Leaf Extract as Part of a Healthy Lifestyle in the Reduction of Blood Pressure
NCT02421835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
\- clinical study to investigate the bioactivity of preparations (biscuits and tea) with dried olive leaves. This is a nutritional intervention - clinical study of cross-over design (cross over design: acute study). The main objective of the study is to investigate the postprandial effect of olive leaves, on selected biomarkers and on the antioxidant status of plasma. The participants of the study will be healthy volunteers, aged 18-65 years, who will come from areas of Greece and will be based on the island of Limnos, in order to be able to be present on the days of the study. The study will be carried out in the specially designed space of the Human Nutrition Unit, University of the Aegean, in collaboration with external doctors. The total duration of the study will be 15 days (3 axes). Participants will be randomly divided into three groups. On the first day, the first group will consume a meal rich in carbohydrates and fats, which will consist of 2-3 biscuits made with butter, flour and sugar and drops of caramel coloring (E150a), along with a glass of natural mineral water with the addition of caramel coloring (E150a) at a refrigerator temperature of \~4°C (control group), the second group 2-3 biscuits made with butter, flour and sugar and dried olive leaf powder, along with a glass of natural mineral water with the addition of caramel coloring (E150a) at a refrigerator temperature of \~4°C (intervention group A) and the third group 2-3 biscuits made with butter, flour and sugar and drops of caramel coloring (E150a), along with a glass of tea made from dried olive leaves and natural mineral water at refrigerator temperature \~4°C (intervention group B). In all groups, the meal (control or intervention) will be consumed first and the liquid (control or intervention) will be consumed immediately afterwards. The total time for the meal (biscuits) will be 15 minutes and in the next 10 minutes, the liquid (olive leaf tea or water with caramel coloring) must also be consumed. After 7 days (washout period), the same volunteers will come to the specially designed area and the procedure will be repeated, with the difference that the control group on day 1 will belong to intervention group A, intervention group A will belong to intervention group B and intervention group B will belong to the control group. Finally, on the 15th day, the procedure will be repeated with the same volunteers, where the control group of the 1st day will now belong to the intervention group B, the intervention group A will belong to the control group and the intervention group B will belong to the intervention group A. On all 3 days, blood will be taken for analysis from the participants before, as well as 60, 120 and 240 minutes after the meals. Statistical processing of the results of the analyses will follow to present data regarding the postprandial levels of selected biomarkers and the antioxidant status of plasma.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The individuals will consume 2-3 pieces of biscuits with caramel coloring (total 120 g) and a glass (250 mL) of tea (natural mineral water with caramel coloring) for the control group
Olive Leaf tea
Individuals will consume 2-3 pieces of biscuits with caramel coloring (total 120 g) and a glass (250 mL) of tea (natural mineral water with 1.25 g. dried olive leaves)
Olive Leaf biscuit
The individuals will consume 2-3 pieces of biscuits with 1.25 g. dried olive leaf powder (total 121.25 g) and a glass (250 mL) of tea (natural mineral water with caramel coloring)
Olive Leaf tea
Individuals will consume 2-3 pieces of biscuits with caramel coloring (total 120 g) and a glass (250 mL) of tea (natural mineral water with 1.25 g. dried olive leaves)
Olive Leaf tea
Individuals will consume 2-3 pieces of biscuits with caramel coloring (total 120 g) and a glass (250 mL) of tea (natural mineral water with 1.25 g. dried olive leaves)
Olive Leaf tea
Individuals will consume 2-3 pieces of biscuits with caramel coloring (total 120 g) and a glass (250 mL) of tea (natural mineral water with 1.25 g. dried olive leaves)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Olive Leaf tea
Individuals will consume 2-3 pieces of biscuits with caramel coloring (total 120 g) and a glass (250 mL) of tea (natural mineral water with 1.25 g. dried olive leaves)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-65 years at the start of the study
* Signed written consent to participate in the study and access by doctors to their medical history (diseases, medication)
Exclusion Criteria
* Professional athletes
* People taking contraceptive treatment in the last 3 months
* People with a history of food allergy with hypersensitivity to any of the components of the administered product (e.g. milk protein or allergy-hypersensitivity to plants of the Oleaceae family) People taking supplements (e.g. antioxidants) or drugs that affect intestinal function (e.g. antibiotics) in the last 3 months or medication (hypoglycemic drugs or antihypertensive drugs or diuretics) that may interact with the administered product
* People taking any medication or supplement that may affect metabolism (e.g. GLP-1 analogues and receptor agonists, caffeine supplement, supplements weight loss/gain)
* Pregnant, lactating or menopausal women
* Individuals with substance abuse (drugs) or chronic alcoholism or total daily alcohol intake \> 50 g/d
* Individuals with a chronic condition (history of cardiovascular disease, cancer, diabetes, hypertension, hyperlipidemia, neurological and neuropsychological disorders, active liver disease, severe renal dysfunction, severe stroke and conditions associated with increased risk of bleeding)
* Individuals with any other serious medical condition that may affect the individual's ability to participate in a nutritional intervention study.
* Individuals whose dietary preferences do not allow them to do so (e.g., vegetarians, vegans)
* Individuals who are not willing to comply with the study protocol and the periods of fasting and eating
* Individuals who are considered unreliable by the researcher or have a shorter life expectancy than the expected duration of the study, due to some disease or if they are in any condition that, in the opinion of the researcher, does not allow their safe participation in the study (drug addiction, alcohol abuse)
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of the Aegean
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ANTONIOS KOUTELIDAKIS
Associate Proffessor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lab of Human Nutrition and Public Health
Myrina, Limnos, Greece
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OliherbCT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.